Search by Drug Name or NDC

    NDC 55150-0207-20 Meropenem 500 mg/1 Details

    Meropenem 500 mg/1

    Meropenem is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is MEROPENEM.

    Product Information

    NDC 55150-0207
    Product ID 55150-207_51488d0e-d063-466f-8591-ae2fa7cc88bc
    Associated GPIs 16150050002120
    GCN Sequence Number 026488
    GCN Sequence Number Description meropenem VIAL 500 MG INTRAVEN
    HIC3 W1S
    HIC3 Description CARBAPENEM ANTIBIOTICS (THIENAMYCINS)
    GCN 67092
    HICL Sequence Number 011254
    HICL Sequence Number Description MEROPENEM
    Brand/Generic Generic
    Proprietary Name Meropenem
    Proprietary Name Suffix n/a
    Non-Proprietary Name Meropenem
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name MEROPENEM
    Labeler Name Eugia US LLC
    Pharmaceutical Class Carbapenems [CS], Penem Antibacterial [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205835
    Listing Certified Through 2024-12-31

    Package

    NDC 55150-0207-20 (55150020720)

    NDC Package Code 55150-207-20
    Billing NDC 55150020720
    Package 10 VIAL in 1 CARTON (55150-207-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
    Marketing Start Date 2017-03-27
    NDC Exclude Flag N
    Pricing Information N/A